Shocking Retatrutide Results Show Double Ozempic Weight Loss
Retatrutide helped adults with type 2 diabetes lose more than twice as much weight as high-dose Ozempic in an 80-week clinical trial.
Eli Lilly
Eli Lilly’s New Weight Loss Drug Retatrutide Shows Explosive Results
Eli Lilly’s new weight loss drug, Retatrutide, cleared crucial trials, showing significant weight loss potential that could impact obesity treatment.
Eli Lilly Stock Soars After Massive Earnings Beat and Updated Outlook
Eli Lilly stock surges as earnings exceed expectations amid booming demand for Zepbound and Mounjaro.
Amazon Stock Rises as Pharmacy Launches Same-Day Delivery for Foundayo
Amazon stock sees a boost with the news of same-day delivery for Eli Lilly’s weight-loss pill Foundayo.
TrumpRx: Landmark Drug Price Cuts for Obesity Medications Announced
TrumpRx introduces significant price reductions for obesity drugs, expanding access for many Americans on Medicare and Medicaid.
